phase readout
saveNCT06502990: Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy
TERMINATEDupdated 23h ago
community read0 votes
Sponsor: Amryt Pharma. Phase: PHASE3. Conditions: Generalized Lipodystrophy
view source ↗
comments(0)
5-min edit window · permanent after that